Potassium sparing diuretics as adjunct to mannitol therapy in neurocritical care patients with cerebral edema: Effects on potassium homeostasis and cardiac arrhythmias

Neurocritical Care

Volumn 16, Issue 2, 2012, Pages 280-285

  Bilotta, Federico ^a,b   Giovannini, Federico ^a   Aghilone, Flavia ^a   Stazi, Elisabetta ^a   Titi, Luca ^a   Zeppa, Ivan Orlando ^a   Rosa, Giovanni ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Canrenone; Cerebral edema; Mannitol; Potassium homeostasis

Indexed keywords

BETAMETHASONE; CANRENONE; FUROSEMIDE; MANNITOL; NIMODIPINE; NORADRENALIN; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT; SODIUM;

ADD ON THERAPY; ADULT; AGED; ARTICLE; BRAIN EDEMA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFECT; FEMALE; HEART ARRHYTHMIA; HUMAN; HYPOKALEMIA; INTENSIVE CARE; MALE; NEUROCRITICAL CARE; POTASSIUM BALANCE; POTASSIUM BLOOD LEVEL; POTASSIUM DEPLETION; POTASSIUM EXCRETION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SODIUM BLOOD LEVEL; URINARY EXCRETION; URINE VOLUME;

AGED; ALDOSTERONE ANTAGONISTS; ARRHYTHMIAS, CARDIAC; BRAIN EDEMA; CANRENONE; CASE-CONTROL STUDIES; DIURETICS, OSMOTIC; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPOKALEMIA; MALE; MANNITOL; MIDDLE AGED; POTASSIUM; PROSPECTIVE STUDIES;

EID: 84860886467     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-011-9652-2     Document Type: Article

References (19)

1. Warren SE, Blantz RC. Mannitol. Arch Intern Med. 1981;141: 493.
2. D'Mello SR, Galli C, Ciotti T. Induction of apoptosis in cere-bellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc Natl Acad Sci USA. 1993;90:10989-109993.
3. Andersson B, Janson V, Behnam-Motlagh P, et al. Induction of apoptosis by intracellular potassium ion depletion: using the fluorescent dye PBFI in 96-well plate method in cultured lung cancer cells. Toxicol In Vitro. 2006;20(6):986-94.
4. Bilotta F, Pizzichetta F, Fiorani L, et al. Risk index for periop-erative atrial fibrillation in patients undergoing open intracranial neurosurgical procedures. Anaesthesia. 2009;64(5):503-7.
5. Golanov EV, Christensen JD, Reis DJ. Role of potassium channels in the central neurogenic neuroprotection elicited by cerebellar stimulation in rats. Brain Res. 1999;842(2):496-500. (Pubitemid 29475188)
6. Clark SL, Cunningham JL, Rabinstein AA, et al. Electrolyte orders in the neuroscience intensive care worth the value or waste? Neurocrit Care. 2011;14:216-21.
7. Boccanelli A, Mureddu GF, Cacciatore G, et al. Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results. Eur J Heart Fail. 2009;11: 68-76.
8. Cruz CS, Cruz LS, Domingues GS, Souza CA, et al. New strategies for treatment of the heart failure with aldosterone antagonists and the risk of hyperkaliemia. Expert Opin Drug Saf. 2005;4:677-88. (Pubitemid 40946066)
9. Nassiacos D, Meloni S. Tolerability and efficacy of aldosterone inhibition with canrenone in heart failure: the real-world experience o fan outpatient heart failure clinic. Ital Heart J. 2005;6(suppl 1): 51S-65S. (Pubitemid 41825601)
10. Raslan A, Bhardwaj A. Medical management of cerebral edema. Neurosurg Focus. 2007;22(5):E12-23.
11. Chien KL, Hsu HC, Chen PC, et al. Urinary sodium and potassium excretion and risk of hypertension in Chinese: report from a community-based cohort study in Taiwan. J Hypertens. 2008;26:1750-6.
12. Hamill-Ruth R, McGory R. Magnesium repletion and its effect on potassium homeostasis in critically ill adults: results of a double-blind, randomized, controlled trial. Crit Care Med. 1996;24(1):38-45.
13. Polanczyk CA, Goldman L, Marcantonio ER, et al. Supraven-tricular arrhythmia in patients having noncardiac surgery: clinical correlates and effect on length of stay. Ann Intern Med. 1998;129:279-85. (Pubitemid 28394572)
14. Buckley MS, LeBlanc JM, Cawley MJ. Electrolyte disturbances associated with commonly prescribed medications in the intensive care unit. Crit Care Med. 2010;38(6):S253-64.
15. Francony G, Fauvage B, Falcon D, Canet C, Dilou H, Lavagne P, Jacquot C, Payen JF. Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure. Crit Care Med. 2008;36(3):795-800.
16. Castillo LB, Bugedo GA, Paranhos JL. Mannitol or hypertonic saline for intracranial hypertension? A point of view. Crit Care Resusc. 2009;11(2):151-4.
17. Pettilä V, Cooper DJ. Treating intracranial hypertension: time to abandon mannitol? Crit Care Resusc. 2009;11(2):94-5.
18. Bantel C, Maze M, Trapp S. Neuronal preconditioning by inhalation of anesthetics. Anesthesiology. 2009;110:986-95.
19. NordrehaugE,JohannessenKA,VonDerLippeG.Serumpotassium concentrationasarisk factorofventricular arrhythmias earlyinacute myocardial infarction. Circulation. 1985, 71(4)645-9. (Pubitemid 15099112)